Clinical Trial Update: Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE [Phase 3]

View source ↗

Summary

Phase 3 trial comparing catheter-directed thrombolysis to anticoagulation monotherapy in intermediate-high risk pulmonary embolism was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Pulmonary Embolism, Pulmonary Thromboembolisms | Phase 3 | Status: TERMINATED